Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volociximab + Gemcitabine in Metastatic Pancreatic Cancer
NCT00401570Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Mar 2005
- Primary completion
- Jun 2008
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of volociximab, sponsored by AbbVie Inc.. Started Mar 2005; status: completed.
02
Drugs
volociximab
Beyond the preview
Go deeper on NCT00401570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00401570.